CBIO - Catalyst Biosciences, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5331.71M
Enterprise Value 3272.84M
Trailing P/E N/A
Forward P/E 1-5.74
PEG Ratio (5 yr expected) 10.53
Price/Sales (ttm)325.85
Price/Book (mrq)5.51
Enterprise Value/Revenue 3268.01
Enterprise Value/EBITDA 6-12.60

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Dec 31, 2017

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-2,143.61%

Management Effectiveness

Return on Assets (ttm)-35.15%
Return on Equity (ttm)-92.05%

Income Statement

Revenue (ttm)1.02M
Revenue Per Share (ttm)0.30
Quarterly Revenue Growth (yoy)347.90%
Gross Profit (ttm)1.02M
EBITDA -21.65M
Net Income Avi to Common (ttm)-25.51M
Diluted EPS (ttm)-7.45
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)32.44M
Total Cash Per Share (mrq)2.73
Total Debt (mrq)5.08M
Total Debt/Equity (mrq)16.52
Current Ratio (mrq)4.47
Book Value Per Share (mrq)5.06

Cash Flow Statement

Operating Cash Flow (ttm)-19.94M
Levered Free Cash Flow (ttm)2.26M

Trading Information

Stock Price History

Beta 2.58
52-Week Change 3434.33%
S&P500 52-Week Change 310.49%
52 Week High 337.00
52 Week Low 33.11
50-Day Moving Average 326.40
200-Day Moving Average 317.33

Share Statistics

Avg Vol (3 month) 3379.61k
Avg Vol (10 day) 3123.72k
Shares Outstanding 511.89M
Float 10.69M
% Held by Insiders 11.33%
% Held by Institutions 138.92%
Shares Short 3414.75k
Short Ratio 35.9
Short % of Float 310.11%
Shares Short (prior month) 3432.25k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Aug 19, 2015
Ex-Dividend Date 4Aug 20, 2015
Last Split Factor (new per old) 21/15
Last Split Date 3Feb 13, 2017